Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis Through ATF4 and KLF9 in Medullary Thyroid Cancer

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Calcium/Calmodulin-Dependent Protein Kinase II and Its Endogenous Inhibitor in Medullary Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells With Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

OSGIN1 (Oxidative Stress Induced Growth Inhibitor 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2015English

Steroid-Sparing Therapy for Tyrosine Kinase Inhibitor–Induced Pneumonitis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer

Experimental & Molecular Medicine
2016English

Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2014English

Checkpoint Kinase Inhibitor AZD7762 Enhance Cisplatin-Induced Apoptosis in Osteosarcoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy